Determination of the effect of sedative of Dexmedetomidine and Fentanyl with Ketamine and Fentanyl in participants undergoing colonoscopy

The comparison of the effect of sedative of Dexmedetomidine and Fentanyl in comparison with Ketamine and Fentanyl in participants undergoing colonoscopy

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170805035510N5

Enrollment

Registered

2019-07-28

Start date

2018-04-21

Completion date

Unknown

Last updated

2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Participants candidates for colonoscopy dignosis.

Interventions

Intervention 1: Intervention group: Combination of Ketamine and Fentanyl, Once before colonoscopy the dosage was injectable ketamine (ketamine hydrochloride 500 mg / ml or 0.5 mg/kg) and fentanyl (fen

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients wwith anesthetic condition ASA Class I, II

Exclusion criteria

Exclusion criteria: Patients with complete heart block Liver failure Severe heart failure

Design outcomes

Primary

Measure	Time frame
Sedation. Timepoint: During colonoscopy and one minute after colonoscopy. Method of measurement: Visual Analogue Scale (VAS).;Pain. Timepoint: One minute after colonoscopy. Method of measurement: Visual Analogue Scale (VAS).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactPejman Pourfakhr

Tehran University of Medical Sciences

pourfakhr@tums.ac.ir+98 21 8863 5770

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026